RenovoRx, Inc. (RNXT)

1.67 +0.19 (+12.84%) USD  |  NASDAQ  |  Aug 28, 16:00
1.70 +0.03 (+1.80%) After-Hours: 20:00
More

RenovoRx Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for RNXT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 28, 2026 --
August 19, 2026 --
August 14, 2026 --
August 13, 2026 --
July 29, 2026 --
June 01, 2026 --
May 15, 2026 --
April 28, 2026 --
April 09, 2026 --
April 08, 2026 --
March 31, 2026 --
February 17, 2026 --
February 09, 2026 --
January 29, 2026 --
November 22, 2025 --
November 18, 2025 --
November 14, 2025 --
Date Value
August 27, 2025 --
August 18, 2025 --
August 15, 2025 --
June 05, 2025 --
May 19, 2025 --
May 16, 2025 --
April 27, 2025 --
April 04, 2025 --
April 02, 2025 --
March 27, 2025 --
December 10, 2024 --
November 14, 2024 --
September 12, 2024 --
August 14, 2024 --
June 17, 2024 --
May 15, 2024 --
April 15, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade